Flavoprotein Autofluorescence Imaging in AMD
AMD 中的黄素蛋白自发荧光成像
基本信息
- 批准号:8953161
- 负责人:
- 金额:$ 20.64万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-09-30 至 2017-09-29
- 项目状态:已结题
- 来源:
- 关键词:AcuteAffectAge related macular degenerationAgingAlgorithmsAnimalsBiological MarkersBruch&aposs basal membrane structureCell Culture TechniquesCellsCessation of lifeCharacteristicsChronicCicatrixClinicClinicalClinical ResearchCompanionsComputer softwareCoupledCultured CellsCytosolDepositionDeveloped CountriesDevicesDiseaseDisease modelDrug TargetingDrusenElderlyElectron TransportExperimental Animal ModelExposure toExtracellular MatrixExudative age-related macular degenerationEyeFlavoproteinsFluorescence SpectroscopyFrequenciesFunctional disorderGeneticGoalsHealthHemorrhageHistopathologyHumanHydroquinonesImageImaging DeviceIndividualInduced MutationInjection of therapeutic agentLasersLegal BlindnessLifeLipidsLipofuscinMeasuresMediatingMetabolismMethodsMitochondriaMitochondrial DNAMusOphthalmoscopesOphthalmoscopyOpticsOxidantsOxidasesOxidative PhosphorylationPathogenesisPathway interactionsPatientsPharmaceutical PreparationsPhospholipidsPhotoreceptorsPigment Epithelium of EyePilot ProjectsPlasmaPopulationProductionProteomicsReperfusion InjuryResearchRetinaRetinalRetinal DiseasesRoleScanningSocietiesSourceStagingStructure of retinal pigment epitheliumSuperoxidesSystemTechnologyTherapeuticTimeTissuesToxic Environmental SubstancesUnited StatesVascular Endothelial Growth FactorsWorkabsorptionage relatedbaseclinical applicationdesigneffective therapyextracellulargeographic atrophyhuman subjecthydroquinoneimage processingimaging biomarkerimprovedin vivomitochondrial dysfunctionmouse modelnoveloptical spectrapre-clinicalprogramsprotein expressionprototypepublic health relevancerepairedresponse to injury
项目摘要
DESCRIPTION (provided by applicant): In developed societies, age-related macular degeneration (AMD) is the most common cause of legal blindness in people over age 65. Emerging evidence demonstrates an important role for retinal pigment epithelium (RPE) mitochondrial dysfunction in dry AMD pathobiology. Mitochondrial dysfunction is characterized by chronic overproduction of superoxide and diminished production of ATP, and it promotes activation of injury response pathways in RPE cells, leading to sub-RPE deposit formation (precursors of lipid-rich drusen) and dysregulation of extracellular matrix turnover, the hallmark features of dry AMD. Thus, mitochondrial-targeting drugs are emerging as an attractive class of potential therapeutics for dry AMD. Technologies to identify the presence of RPE mitochondrial dysfunction in living eyes are limited. Detecting mitochondrial dysfunction in vivo would enable selection of individuals who might benefit from mitochondria-targeting drugs and would accelerate mechanistic studies of mitochondrial dysfunction in dry AMD disease models. The goal of this project is to develop RPE flavoprotein autofluorescence as an imaging biomarker for mitochondrial dysfunction. Mitochondrial dysfunction is accompanied by an increased ratio in the oxidized to reduced forms of flavoproteins (especially FAD+), which are important components of the electron transport chain for ATP production. Increase in oxidized flavoprotein produces a characteristic shift in the autofluorescence emission spectra, which is easily measured in isolated cells or tissues. However, detecting this shift noninvasively in tissues of living animals or humans, especially the eye, is much more challenging. It requires both a specialized device to image the RPE and an analytical approach to detect the specific autofluorescence signature attributable to flavoprotein. In this project, we will design and build prototype multispectral imaging device using a rapidly tunable excitation laser source, an acousto-optical tunable barrier filter, and a confocal scanning laser ophthalmoscope retinal imager, integrated with analytical software based on synchronous fluorescence spectroscopy, to detect and quantify RPE flavoprotein autofluorescence. We will use cell culture and animal model experimental systems to develop and validate this technology, and we will adapt the integrated multispectral imaging device to initiate a pilot clinical study of RPE flavoprotein autofluorescence in human subjects without retinal disease and in subjects with AMD.
描述(由适用提供):在发达的社会中,与年龄相关的黄斑变性(AMD)是65岁以上人群的法律失明的最常见原因。新兴证据表明,视网膜色素上皮(RPE)线粒体功能障碍在干燥AMD病理生物学中起着重要作用。线粒体功能障碍的特征是超氧化物的慢性产生和ATP的产生减少,并且促进了RPE细胞中损伤反应途径的激活,导致子RPE沉积物形成(脂质富含富含脂质的龙的前体)和细胞外基质失误的失调,并具有干燥的基质流失,Dry Amd的Hallmark特征。这就是线粒体靶向药物正在成为一种有吸引力的干室疗法类别。在活眼睛中识别RPE线粒体功能障碍的技术是有限的。在体内检测线粒体功能障碍将使可以选择可能从靶向线粒体靶向药物中受益的个体,并将加速干燥AMD疾病模型中线粒体功能障碍的机理研究。该项目的目的是开发RPE黄蛋白自动荧光作为线粒体功能障碍的成像生物标志物。线粒体功能障碍是通过氧化与还原形式的黄素蛋白(尤其是FAD+)的比例增加的,这是电子传输链的重要组成部分,以产生ATP的产生。氧化的黄素蛋白的增加会在自动荧光发射光谱中产生特征转移,该光谱很容易在分离的细胞或组织中测量。但是,在活动物或人类(尤其是眼睛)的组织中无创的这种转变是更大的挑战。它既需要一个专门的设备来对RPE进行成像,也需要一种分析方法来检测归因于黄蛋白的特定自动荧光特征。在这个项目中,我们将使用快速调谐激光源设计和构建原型多光谱成像设备,一个仿光光学的可调屏障过滤器以及共聚焦扫描激光视网膜视网膜成像仪,与基于同步荧光光谱和量化flavuere rpe的分析软件集成,并与分析软件集成。我们将使用细胞培养和动物模型实验系统来开发和验证这项技术,并将适应综合的多光谱成像装置,以启动无残留疾病和AMD受试者的人类受试者的RPE氟蛋白自动荧光的临床研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SCOTT W COUSINS其他文献
SCOTT W COUSINS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SCOTT W COUSINS', 18)}}的其他基金
Mitochondrial Dysfunction in a New Model of Dry AMD
新型干性 AMD 中的线粒体功能障碍
- 批准号:
9333371 - 财政年份:2016
- 资助金额:
$ 20.64万 - 项目类别:
Vascular Progenitor Cells in Neovascular AMD
新生血管性 AMD 中的血管祖细胞
- 批准号:
7797367 - 财政年份:2008
- 资助金额:
$ 20.64万 - 项目类别:
Vascular Progenitor Cells in Neovascular AMD
新生血管性 AMD 中的血管祖细胞
- 批准号:
7440769 - 财政年份:2008
- 资助金额:
$ 20.64万 - 项目类别:
Vascular Progenitor Cells in Neovascular AMD
新生血管性 AMD 中的血管祖细胞
- 批准号:
8114007 - 财政年份:2008
- 资助金额:
$ 20.64万 - 项目类别:
Vascular Progenitor Cells in Neovascular AMD
新生血管性 AMD 中的血管祖细胞
- 批准号:
8249090 - 财政年份:2008
- 资助金额:
$ 20.64万 - 项目类别:
Vascular Progenitor Cells in Neovascular AMD
新生血管性 AMD 中的血管祖细胞
- 批准号:
7586099 - 财政年份:2008
- 资助金额:
$ 20.64万 - 项目类别:
AGING AND VASCULOGENESIS IN MACULAR DEGENERATION
黄斑变性中的衰老和血管生成
- 批准号:
7164428 - 财政年份:2004
- 资助金额:
$ 20.64万 - 项目类别:
AGING AND VASCULOGENESIS IN MACULAR DEGENERATION
黄斑变性中的衰老和血管生成
- 批准号:
6719966 - 财政年份:2004
- 资助金额:
$ 20.64万 - 项目类别:
NEI Mentored Clincial Scientist Development Program Award (K12)
NEI 指导临床科学家发展计划奖 (K12)
- 批准号:
8513331 - 财政年份:2004
- 资助金额:
$ 20.64万 - 项目类别:
AGING AND VASCULOGENESIS IN MACULAR DEGENERATION
黄斑变性中的衰老和血管生成
- 批准号:
7097760 - 财政年份:2004
- 资助金额:
$ 20.64万 - 项目类别:
相似国自然基金
海洋缺氧对持久性有机污染物入海后降解行为的影响
- 批准号:42377396
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
氮磷的可获得性对拟柱孢藻水华毒性的影响和调控机制
- 批准号:32371616
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
还原条件下铜基催化剂表面供-受电子作用表征及其对CO2电催化反应的影响
- 批准号:22379027
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
CCT2分泌与内吞的机制及其对毒性蛋白聚集体传递的影响
- 批准号:32300624
- 批准年份:2023
- 资助金额:10 万元
- 项目类别:青年科学基金项目
在轨扰动影响下空间燃料电池系统的流动沸腾传质机理与抗扰控制研究
- 批准号:52377215
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Developing multi-specific aptamers for safe, potent, and long-lasting treatment of geographic atrophy
开发多特异性适体以安全、有效且持久地治疗地理萎缩
- 批准号:
10482569 - 财政年份:2022
- 资助金额:
$ 20.64万 - 项目类别:
ER stress-induced translational regulation in retinal degeneration
视网膜变性中内质网应激诱导的翻译调节
- 批准号:
10653971 - 财政年份:2021
- 资助金额:
$ 20.64万 - 项目类别:
Developing an ultrafast fluorescence lifetime imaging ophthalmoscopy system for retinal imaging
开发用于视网膜成像的超快荧光寿命成像检眼镜系统
- 批准号:
10288094 - 财政年份:2021
- 资助金额:
$ 20.64万 - 项目类别:
The effect of donor age on the function and therapeutic efficacy of human hepatocyte-like cells
供者年龄对人肝细胞样细胞功能及治疗效果的影响
- 批准号:
10674009 - 财政年份:2021
- 资助金额:
$ 20.64万 - 项目类别:
The effect of donor age on the function and therapeutic efficacy of human hepatocyte-like cells
供者年龄对人肝细胞样细胞功能及治疗效果的影响
- 批准号:
10646093 - 财政年份:2021
- 资助金额:
$ 20.64万 - 项目类别: